Drug:
Reaction: THERAPY INTERRUPTED
20250101 - 20251231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 25491826 |
US |
1 | |
Therapy interrupted, |
||||
EVOLOCUMAB, |
||||
| 2 | 25491847 |
US |
41 | 2 |
Product distribution issue, Therapy interrupted, |
||||
MAVACAMTEN, |
||||
| 3 | 25491987 |
US |
||
Therapy interrupted, Product availability issue, |
||||
RILUZOLE, |
||||
| 4 | 25492034 |
US |
70 | 2 |
Inability to afford medication, Therapy interrupted, |
||||
| 5 | 25492174 |
US |
82 | 2 |
Therapy interrupted, |
||||
DENOSUMAB, |
||||
| 6 | 25492682 |
US |
70 | 1 |
Therapy interrupted, Product dose omission issue, |
||||
LENALIDOMIDE, |
||||
| 7 | 25492765 |
GB |
2 | |
Rheumatoid arthritis, Therapy interrupted, Product prescribing issue, Therapeutic response shortened, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 8 | 25493054 |
US |
53 | 1 |
Infection, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 9 | 25493221 |
US |
2 | |
Gastroenteritis, Therapy interrupted, |
||||
TROFINETIDE, |
||||
| 10 | 25493421 |
US |
2 | |
Therapy interrupted, |
||||
ISOTRETINOIN, ISOTRETINOIN, |
||||
| 11 | 25493486 |
US |
||
Therapy interrupted, |
||||
RELUGOLIX, |
||||
| 12 | 25493493 |
US |
||
Therapy interrupted, |
||||
RELUGOLIX, RELUGOLIX, ENZALUTAMIDE, |
||||
| 13 | 25493987 |
US |
82 | 1 |
Cardiac failure congestive, Blood pressure abnormal, Abnormal behaviour, Decreased appetite, Gait inability, Dyskinesia, Fatigue, Somnolence, Drug ineffective, Therapy interrupted, Product use in unapproved indication, |
||||
BREXPIPRAZOLE, BREXPIPRAZOLE, BREXPIPRAZOLE, |
||||
| 14 | 25494306 |
US |
65 | 2 |
Therapy interrupted, Inability to afford medication, |
||||
| 15 | 25494346 |
US |
71 | 1 |
Lymphoma, Therapy interrupted, Liquid product physical issue, |
||||
ENSIFENTRINE, |
||||
| 16 | 25494617 |
US |
43 | 2 |
Rheumatoid arthritis, Insurance issue, Therapy interrupted, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 17 | 25494827 |
81 | 2 | |
Influenza, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 18 | 25494930 |
1 | ||
Surgery, Therapy interrupted, |
||||
SELPERCATINIB, CETIRIZINE HCL, CETIRIZINE, SELPERCATINIB, |
||||
| 19 | 25494988 |
77 | 1 | |
Neutropenia, Therapy interrupted, |
||||
POMALIDOMIDE, |
||||
| 20 | 25495140 |
US |
79 | 1 |
Product distribution issue, Off label use, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 21 | 25495514 |
US |
74 | 1 |
Hospitalisation, Therapy interrupted, Insurance issue, |
||||
RIFAXIMIN, |
||||
| 22 | 25496013 |
US |
63 | 2 |
Rheumatoid arthritis, Injection site pain, Therapy interrupted, |
||||
CERTOLIZUMAB PEGOL, DENOSUMAB, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, LEFLUNOMIDE, DICLOFENAC, DICLOFENAC SODIUM, |
||||
| 23 | 25496235 |
CA |
1 | |
Therapy interrupted, |
||||
CLOZAPINE, |
||||
| 24 | 25496525 |
US |
52 | 1 |
Product distribution issue, Therapy interrupted, |
||||
POMALIDOMIDE, |
||||
| 25 | 25499467 |
84 | 2 | |
Fall, Therapy interrupted, |
||||
TAFAMIDIS, |
||||
| 26 | 25503801 |
84 | 1 | |
Fall, Hip arthroplasty, Therapy interrupted, Nausea, |
||||
| 27 | 25504048 |
84 | 2 | |
Hospitalisation, Therapy interrupted, |
||||
AVACOPAN, |
||||
| 28 | 25504052 |
78 | 1 | |
Haemoptysis, Therapy interrupted, |
||||
AVACOPAN, AVACOPAN, |
||||
| 29 | 25491613 |
US |
70 | 2 |
Device difficult to use, Drug dose omission by device, Malaise, Joint swelling, Peripheral swelling, Therapy interrupted, |
||||
ETANERCEPT, PREDNISONE, EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE, CARBAMAZEPINE, ROSUVASTATIN CALCIUM, HYDROXYCHLOROQUINE, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, LORATADINE, LORATADINE ORAL, LEVOTHYROXINE, |
||||
| 30 | 25490206 |
US |
2 | |
Therapy interrupted, |
||||
ETANERCEPT, ETANERCEPT, |
||||
| 31 | 25484589 |
60 | 2 | |
Therapy interrupted, |
||||
| 32 | 25484652 |
52 | 2 | |
Hepatic enzyme increased, Hepatic necrosis, Therapy interrupted, |
||||
ADALIMUMAB, |
||||
| 33 | 25486634 |
US |
64 | 2 |
Therapy interrupted, |
||||
NIVOLUMAB, |
||||
| 34 | 25486710 |
US |
71 | 2 |
Rheumatoid arthritis, Spinal operation, Lower limb fracture, Therapy interrupted, |
||||
PREDNISONE, |
||||
| 35 | 25486919 |
US |
76 | 1 |
Peripheral swelling, Fluid retention, Dyspnoea, Cough, Retching, Post-tussive vomiting, Throat irritation, Therapy interrupted, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, FAMOTIDINE, ALBUTEROL SULFATE, FLUTICASONE PROPIONATE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, NINTEDANIB, BUMETANIDE, OXYGEN, 0XYGEN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, CETIRIZINE HCL, CETIRIZINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, TICAGRELOR, IPRATROPIUM BROMIDE, LOSARTAN POTASSIUM, LOSARTAN, TIOTROPIUM BROMIDE AND OLODATEROL, |
||||
| 36 | 25487156 |
IT |
13 | 2 |
Device computer issue, Therapy interrupted, Drug dose omission by device, Device mechanical issue, |
||||
SOMATROPIN, |
||||
| 37 | 25487581 |
CO |
1 | |
Death, Illness, Intentional dose omission, Therapy interrupted, Insurance issue, Malaise, Injection site mass, Injection site pain, |
||||
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, CALCIUM, |
||||
| 38 | 25487732 |
CO |
53 | 1 |
Gait inability, Pain, Mobility decreased, Therapy interrupted, Product dispensing issue, Off label use, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 39 | 25487932 |
US |
16 | |
Therapy interrupted, |
||||
ISOTRETINOIN, |
||||
| 40 | 25489650 |
US |
79 | 1 |
Hospitalisation, Off label use, Therapy interrupted, |
||||
LENALIDOMIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, ACYCLOVIR, |
||||
| 41 | 25489768 |
AR |
36 | 2 |
Rheumatoid arthritis, Therapy interrupted, |
||||
ADALIMUMAB-ADAZ, |
||||
| 42 | 25489844 |
US |
||
Insurance issue, Therapy interrupted, |
||||
| 43 | 25490574 |
CA |
2 | |
Therapy interrupted, |
||||
CLOZAPINE, CLOZAPINE, |
||||
| 44 | 25493554 |
1 | ||
White blood cell count decreased, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 45 | 25493562 |
66 | 2 | |
Pneumonia, Atrial fibrillation, Therapy interrupted, |
||||
DUPILUMAB, |
||||
| 46 | 25493800 |
75 | 2 | |
Rash, Therapy interrupted, |
||||
IXEKIZUMAB, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, BUPRENORPHINE HYDROCHLORIDE, BUPROPION, EMPAGLIFLOZIN, LINACLOTIDE, LISINOPRIL, MELOXICAM, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 47 | 25494220 |
74 | 1 | |
Cerebrovascular accident, Viral infection, Therapy interrupted, |
||||
TACROLIMUS, TACROLIMUS, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, VALGANCICLOVIR HYDROCHLORIDE, VALGANCICLOVIR, VALGANCICLOVIR HYDROCHLORIDE POWDER,, FEBUXOSTAT, FEBUXOSTAT TABLETS 40 MG, FEBUXOSTAT TABLETS 80 MG, SULFAMETHOXAZOLE AND TRIMETHOPRIM, AMLODIPINE, CARVEDILOL, ERGOCALCIFEROL, |
||||
| 48 | 25494531 |
78 | 1 | |
Urinary retention, Haemorrhage, Thrombosis, Therapy interrupted, |
||||
UPADACITINIB, |
||||
| 49 | 25494542 |
35 | 2 | |
Pregnancy, Therapy interrupted, Exposure during pregnancy, |
||||
IXEKIZUMAB, |
||||
| 50 | 25481165 |
US |
1 | |
Hospitalisation, Therapy interrupted, |
||||
AMIKACIN, |
||||
| 51 | 25481423 |
US |
88 | 1 |
Product supply issue, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 52 | 25481631 |
US |
||
Unevaluable event, Therapy interrupted, |
||||
VIBEGRON, |
||||
| 53 | 25481699 |
CO |
59 | 1 |
Blood urine present, Headache, Dizziness, Balance disorder, Pain, Nausea, Fall, Off label use, Therapy interrupted, Product dispensing issue, |
||||
ROTIGOTINE, ROTIGOTINE, ROTIGOTINE, ROTIGOTINE, ROTIGOTINE, |
||||
| 54 | 25481702 |
CA |
56 | |
Hip arthroplasty, Procedural haemorrhage, Therapy interrupted, |
||||
ICOSAPENT ETHYL, ICOSAPENT ETHYL, |
||||
| 55 | 25481771 |
US |
63 | 2 |
Knee arthroplasty, Therapy interrupted, Insurance issue, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 56 | 25482399 |
US |
||
Therapy interrupted, |
||||
CARFILZOMIB, |
||||
| 57 | 25482594 |
US |
74 | 1 |
Product distribution issue, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 58 | 25482606 |
CA |
||
Intestinal perforation, Therapy interrupted, Product distribution issue, Intentional product use issue, Intentional dose omission, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 59 | 25483015 |
38 | 2 | |
Platelet count decreased, Therapy interrupted, |
||||
CARBOPLATIN, PACLITAXEL, |
||||
| 60 | 25483312 |
1 | ||
Therapy interrupted, |
||||
IMATINIB, FINASTERIDE, IMATINIB MESYLATE, IMATINIB, |
||||
| 61 | 25483610 |
74 | 1 | |
Pneumonia, Pulmonary thrombosis, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 62 | 25483794 |
75 | 1 | |
Spinal fusion surgery, Therapy interrupted, |
||||
RISANKIZUMAB-RZAA, |
||||
| 63 | 25484029 |
|||
Therapy interrupted, |
||||
LOTILANER OPHTHALMIC SOLUTION, |
||||
| 64 | 25484445 |
68 | 1 | |
Bronchitis, Therapy interrupted, |
||||
ADALIMUMAB, ADALIMUMAB, |
||||
| 65 | 25484544 |
2 | ||
White blood cell count decreased, Therapy interrupted, |
||||
RIBOCICLIB, |
||||
| 66 | 25486026 |
US |
||
Pancreatitis, Product dispensing issue, Therapy interrupted, Product dispensing issue, Therapy interrupted, Anal incontinence, Rhinorrhoea, Diarrhoea, |
||||
PANCRELIPASE LIPASE, PANCRELIPASE PROTEASE, PANCRELIPASE AMYLASE, PANCRELIPASE LIPASE, PANCRELIPASE PROTEASE, PANCRELIPASE AMYLASE, PHYTONADIONE, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, MESALAMINE, MELATONIN, ZOLPIDEM TARTRATE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DORZOLAMIDE, METOPROLOL TARTRATE, METOPROLOL, |
||||
| 67 | 25486132 |
US |
71 | 2 |
Pain, Therapy interrupted, |
||||
AMLODIPINE BESYLATE, DICLOFENAC POTASSIUM, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DOCUSATE CALCIUM, STOOL SOFTENER, MAGNESIUM HYDROXIDE, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, ERGOCALCIFEROL, FOLIC ACID, POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, RIZATRIPTAN BENZOATE, MECLIZINE HYDROCHLORIDE, MECLIZINE HCL, MECLIZINE, MECLIZINE HYDROCLORIDE, MELATONIN, METHOTREXATE, METHOTREXATE SODIUM, IBUPROFEN, IBUPROFEN AND DIPHENHYDRAMINE CITRATE, NORTRIPTYLINE HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, |
||||
| 68 | 25486284 |
US |
77 | 1 |
Wrong technique in product usage process, Device difficult to use, Blood cholesterol increased, Drug dose omission by device, Therapy interrupted, |
||||
EVOLOCUMAB, EVOLOCUMAB, |
||||
| 69 | 25475894 |
US |
67 | 2 |
Product distribution issue, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 70 | 25475907 |
CA |
50 | 2 |
Syncope, Fear of injection, Pain, Product use complaint, Injection site pain, Therapy interrupted, Gastroenteritis viral, Vomiting, Pyrexia, Infusion site pain, Fear of injection, Fear of injection, Nausea, Gastroenteritis viral, Abdominal distension, Anxiety, Infusion site discomfort, Infusion site pain, Fear of injection, Fungal infection, Nausea, Pain, Pain in extremity, Dizziness, |
||||
ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, QUETIAPINE FUMARATE, QUETIAPINE, HYDROCHLOROTHIAZIDE, GABAPENTIN, RIVAROXABAN, NORTRIPTYLINE HYDROCHLORIDE, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, ROSUVASTATIN CALCIUM, SEMAGLUTIDE, INSULIN LISPRO, INSULIN GLARGINE, EZETIMIBE, SEMAGLUTIDE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, DAPAGLIFLOZIN, LORAZEPAM, |
||||
| 71 | 25476079 |
US |
69 | 1 |
Injection site indentation, Device difficult to use, Drug dose omission by device, Device use error, Therapy interrupted, |
||||
ERENUMAB-AOOE, ERENUMAB-AOOE, |
||||
| 72 | 25476179 |
US |
||
Drug ineffective, Therapy interrupted, |
||||
CYCLOSPORINE OPHTHALMIC SOLUTION, |
||||
| 73 | 25476211 |
US |
2 | |
Condition aggravated, Therapy interrupted, |
||||
CYCLOSPORINE OPHTHALMIC SOLUTION, |
||||
| 74 | 25476409 |
CA |
||
Loss of consciousness, Dizziness, Therapy interrupted, Overdose, Product use issue, Product supply issue, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, |
||||
| 75 | 25476629 |
US |
59 | 1 |
Fall, Rib fracture, Inability to afford medication, Therapy interrupted, |
||||
| 76 | 25476967 |
US |
||
Spinal operation, Therapy interrupted, |
||||
VIBEGRON, |
||||
| 77 | 25477687 |
US |
73 | 1 |
Product distribution issue, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 78 | 25477724 |
CA |
55 | 2 |
Pyrexia, Headache, Hospitalisation, Infusion site swelling, Infusion site erythema, Infusion site pruritus, Asthenia, Abdominal discomfort, Fatigue, Therapy interrupted, Product dose omission issue, |
||||
DEXLANSOPRAZOLE, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, CALCIUM, SULFAMETHOXAZOLE AND TRIMETHOPRIM, TECLISTAMAB, |
||||
| 79 | 25477775 |
US |
||
Heart rate increased, Feeling abnormal, Pollakiuria, Urinary retention, Hot flush, Therapy interrupted, Wrong technique in product usage process, |
||||
VIBEGRON, VIBEGRON, TAMSULOSIN HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, AMLODIPINE, PANTOPRAZOLE, PANTOPRAZOLE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, GABAPENTIN, |
||||
| 80 | 25477787 |
US |
45 | 1 |
Seizure, Therapy interrupted, Product availability issue, Product use in unapproved indication, |
||||
BRIVARACETAM, BRIVARACETAM, BRIVARACETAM, BRIVARACETAM, |
||||
| 81 | 25478035 |
US |
||
Nausea, Headache, Therapy interrupted, |
||||
VIBEGRON, |
||||
| 82 | 25478212 |
CA |
33 | 2 |
Transcription medication error, Hepatic pain, Paraesthesia, Delayed recovery from anaesthesia, Product size issue, Therapy interrupted, Alopecia, Joint swelling, Temperature regulation disorder, Brain fog, Feeling abnormal, Headache, Vaginal disorder, Blood pressure systolic increased, Chills, Breast pain, Rash, Product availability issue, Anorectal disorder, Product physical issue, Hypoxia, Product substitution issue, Photosensitivity reaction, Product colour issue, Swelling, Hyperhidrosis, Condition aggravated, Cognitive disorder, Product formulation issue, Gastrointestinal pain, Anxiety, Withdrawal syndrome, Peripheral swelling, Sedation complication, Product taste abnormal, Rash erythematous, Inadequate analgesia, Dysphagia, Suspected product tampering, Drug interaction, Bradypnoea, Urinary tract pain, Abdominal pain, Underdose, Dyspnoea, Heart rate increased, Tremor, Product physical consistency issue, Product shape issue, Dyspepsia, Arthralgia, Pain, Burning sensation, Product dosage form issue, Drug ineffective, Haemorrhage, Respiratory depression, Blood pressure diastolic increased, Attention deficit hyperactivity disorder, |
||||
ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, MORPHINE, NIRMATRELVIR AND RITONAVIR, REMIFENTANIL HYDROCHLORIDE, LISDEXAMFETAMINE DIMESYLATE, AMITRIPTYLINE HYDROCHLORIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, |
||||
| 83 | 25478294 |
GB |
2 | |
Cellulitis, Drug ineffective, Therapy interrupted, |
||||
GLATIRAMER ACETATE, GLATIRAMER, GLATIRAMER ACETATE, GLATIRAMER, GLATIRAMER ACETATE, GLATIRAMER, GLATIRAMER ACETATE, GLATIRAMER, |
||||
| 84 | 25478514 |
66 | 2 | |
Therapy interrupted, Gait inability, Fear of falling, Joint noise, Alopecia, |
||||
TRIAMCINOLONE ACETONIDE EXTENDED-RELEASE INJECTABLE SUSPENSION, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, DULOXETINE HYDROCHLORIDE, DULOXETINE, ROSUVASTATIN, SPIRONOLACTONE, ERGOCALCIFEROL, MAGNESIUM, BIOTIN, POLYETHYLENE GLYCOL 3350, CETIRIZINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 85 | 25478556 |
27 | 2 | |
Withdrawal syndrome, Pruritus, Urticaria, Angioedema, Loss of personal independence in daily activities, Corneal cyst, Drug exposure before pregnancy, Therapy interrupted, Symptom recurrence, |
||||
CETIRIZINE HYDROCHLORIDE, FAMOTIDINE, |
||||
| 86 | 25478623 |
2 | ||
Cardiac ablation, Cardiac disorder, Therapy interrupted, Memory impairment, |
||||
AMBRISENTAN, AMOXICILLIN, FUROSEMIDE, LEVOTHYROXINE, MANNITOL, GUAIFENESIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, SILDENAFIL CITRATE, SILDENAFIL, SILDENAFIL POWDER,, |
||||
| 87 | 25478686 |
78 | 1 | |
Vascular graft, Therapy interrupted, |
||||
ETANERCEPT, |
||||
| 88 | 25478743 |
2 | ||
Diverticulitis, Abscess intestinal, Infection, Therapy interrupted, Fear of surgery, |
||||
ICATIBANT ACETATE, LANADELUMAB-FLYO, |
||||
| 89 | 25478877 |
US |
2 | |
Transient ischaemic attack, Eye irritation, Therapy interrupted, |
||||
CENEGERMIN-BKBJ, CENEGERMIN-BKBJ, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN, LOTEPREDNOL ETABONATE, METHOCARBAMOL, METHOCARBAMOL TABLETS, PAROXETINE HYDROCHLORIDE, AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE, |
||||
| 90 | 25478938 |
2 | ||
Pancreatitis, Therapy interrupted, Liver function test increased, |
||||
ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR, ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR, PANCRELIPASE, MONTELUKAST SODIUM, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, |
||||
| 91 | 25479055 |
US |
2 | |
Psoriatic arthropathy, Oophorectomy, Ovarian cyst, Psoriasis, Therapy interrupted, Insurance issue, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 92 | 25479122 |
US |
2 | |
Dry eye, Therapy interrupted, Product delivery mechanism issue, |
||||
CYCLOSPORINE OPHTHALMIC SOLUTION, |
||||
| 93 | 25479208 |
55 | 2 | |
Anxiety, Nervousness, Tremor, Fatigue, Depression, Paranoia, Insomnia, Feeling abnormal, Crying, Disturbance in social behaviour, Panic disorder, Therapy interrupted, Loss of personal independence in daily activities, Mental disorder, |
||||
PREDNISONE, |
||||
| 94 | 25479456 |
IN |
53 | 1 |
Ultrafiltration failure, Inadequate peritoneal dialysis, Product supply issue, Therapy interrupted, |
||||
SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE, ICODEXTRIN, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, |
||||
| 95 | 25479457 |
IN |
58 | 2 |
Ultrafiltration failure, Inadequate peritoneal dialysis, Product supply issue, Therapy interrupted, Decreased appetite, |
||||
SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE, ICODEXTRIN, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, |
||||
| 96 | 25479680 |
US |
66 | 2 |
Death, Hospice care, Intra-abdominal fluid collection, Abdominal pain upper, Product use issue, Therapy interrupted, |
||||
RIFAXIMIN, |
||||
| 97 | 25480099 |
US |
77 | 1 |
Therapy interrupted, Product prescribing issue, |
||||
LENALIDOMIDE, AMLODIPINE BESYLATE, CLOPIDOGREL, CLOPIDOGREL BISULFATE, VALSARTAN, VALSARTAN ORAL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ERGOCALCIFEROL, |
||||
| 98 | 25480416 |
US |
||
Therapy interrupted, |
||||
MONOMETHYL FUMARATE, |
||||
| 99 | 25480419 |
US |
||
Therapy interrupted, |
||||
MONOMETHYL FUMARATE, MONTELUKAST SODIUM, CETIRIZINE HYDROCHLORIDE, NIFEDIPINE, FLUTICASONE PROPIONATE, |
||||
| 100 | 25480460 |
CA |
22 | 2 |
Rheumatoid arthritis, Toothache, Pain, Tooth infection, Fungal infection, Tooth extraction, Urinary tract infection, Ear infection, Off label use, Inappropriate schedule of product administration, Therapy interrupted, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, PREDNISONE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-07-29